Patents by Inventor Björn STEINMANN

Björn STEINMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTI-IL-1R3 ANTIBODY AND METHODS OF USE
    Publication number: 20250019452
    Abstract: An antibody that specifically binds to IL-1R3, comprising an antibody heavy chain amino acid sequence of SEQ ID NO: 1 and a light chain amino acid sequence of SEQ ID NO: 2. A pharmaceutical composition is provided comprising the said antibody and a pharmaceutically acceptable diluent, carrier or excipient. Also said antibody for use in treating a disease or disorder in a subject in need thereof. The disease or disorder may be an autoimmune or autoinflammatory disease or disorder.
    Type: Application
    Filed: June 26, 2024
    Publication date: January 16, 2025
    Inventors: Christian LANGE, Ziyu LI, Björn STEINMANN, Hanno SJUTS, Sandra WEIL
  • Humanized anti-IL-1R3 antibody and methods of use
    Patent number: 12054552
    Abstract: An antibody that specifically binds to IL-1R3, comprising an antibody heavy chain amino acid sequence of SEQ ID NO: 1 and a light chain amino acid sequence of SEQ ID NO: 2. A pharmaceutical composition is provided comprising the said antibody and a pharmaceutically acceptable diluent, carrier or excipient. Also said antibody for use in treating a disease or disorder in a subject in need thereof. The disease or disorder may be an autoimmune or autoinflammatory disease or disorder.
    Type: Grant
    Filed: September 21, 2023
    Date of Patent: August 6, 2024
    Assignee: SANOFI BIOTECHNOLOGY
    Inventors: Christian Lange, Ziyu Li, Björn Steinmann, Hanno Sjuts, Sandra Weil
  • HUMANIZED ANTI-IL-1R3 ANTIBODY AND METHODS OF USE
    Publication number: 20240101691
    Abstract: An antibody that specifically binds to IL-1R3, comprising an antibody heavy chain amino acid sequence of SEQ ID NO: 1 and a light chain amino acid sequence of SEQ ID NO: 2. A pharmaceutical composition is provided comprising the said antibody and a pharmaceutically acceptable diluent, carrier or excipient. Also said antibody for use in treating a disease or disorder in a subject in need thereof. The disease or disorder may be an autoimmune or autoinflammatory disease or disorder.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 28, 2024
    Inventors: Michael COOLBAUGH, Christian LANGE, Ziyu LI, Björn STEINMANN, Hanno SJUTS, Sandra WEIL